These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 3207527)

  • 21. Plasma morphine and glucuronide (M3G and M6G) concentrations in hospice inpatients.
    Ashby M; Fleming B; Wood M; Somogyi A
    J Pain Symptom Manage; 1997 Sep; 14(3):157-67. PubMed ID: 9291702
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of food on the comparative pharmacokinetics of modified-release morphine tablet formulations: Oramorph SR and MST Continus.
    Drake J; Kirkpatrick CT; Aliyar CA; Crawford FE; Gibson P; Horth CE
    Br J Clin Pharmacol; 1996 May; 41(5):417-20. PubMed ID: 8735684
    [TBL] [Abstract][Full Text] [Related]  

  • 23. HPLC determination of morphine, morphine-3-glucuronide and morphine-6-glucuronide in human serum of oncological patients after administration of morphine drugs.
    Netriova J; Blahova E; Johanesova Z; Brandsteterova E; Lehotay J; Serdt K; Mocak J
    Pharmazie; 2006 Jun; 61(6):528-34. PubMed ID: 16830402
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Disposition of morphine and its glucuronide metabolites after oral and rectal administration: evidence of route specificity.
    Babul N; Darke AC
    Clin Pharmacol Ther; 1993 Sep; 54(3):286-92. PubMed ID: 8375123
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The bioavailability and pharmacokinetics of subcutaneous, nebulized and oral morphine-6-glucuronide.
    Penson RT; Joel SP; Roberts M; Gloyne A; Beckwith S; Slevin ML
    Br J Clin Pharmacol; 2002 Apr; 53(4):347-54. PubMed ID: 11966664
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Plasma levels of morphine and morphine glucuronides in the treatment of cancer pain: relationship to renal function and route of administration.
    Peterson GM; Randall CT; Paterson J
    Eur J Clin Pharmacol; 1990; 38(2):121-4. PubMed ID: 2338107
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Day-to-day variations during clinical drug monitoring of morphine, morphine-3-glucuronide and morphine-6-glucuronide serum concentrations in cancer patients. A prospective observational study.
    Klepstad P; Hilton P; Moen J; Kaasa S; Borchgrevink PC; Zahlsen K; Dale O
    BMC Clin Pharmacol; 2004 Oct; 4():7. PubMed ID: 15461818
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CSF and plasma concentrations of morphine and morphine glucuronides in cancer patients receiving epidural morphine.
    Samuelsson H; Hedner T; Venn R; Michalkiewicz A
    Pain; 1993 Feb; 52(2):179-185. PubMed ID: 8455965
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Routine drug monitoring of serum concentrations of morphine, morphine-3-glucuronide and morphine-6-glucuronide do not predict clinical observations in cancer patients.
    Klepstad P; Borchgrevink PC; Dale O; Zahlsen K; Aamo T; Fayers P; Fougner B; Kaasa S
    Palliat Med; 2003 Dec; 17(8):679-87. PubMed ID: 14694919
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A Prospective Population Pharmacokinetic Study on Morphine Metabolism in Cancer Patients.
    Oosten AW; Abrantes JA; Jönsson S; Matic M; van Schaik RHN; de Bruijn P; van der Rijt CCD; Mathijssen RHJ
    Clin Pharmacokinet; 2017 Jul; 56(7):733-746. PubMed ID: 27815868
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacokinetics and clinical efficacy of oral morphine solution and controlled-release morphine tablets in cancer patients.
    Thirlwell MP; Sloan PA; Maroun JA; Boos GJ; Besner JG; Stewart JH; Mount BM
    Cancer; 1989 Jun; 63(11 Suppl):2275-83. PubMed ID: 2720576
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Plasma concentrations of morphine, morphine-3-glucuronide, and morphine-6-glucuronide after intravenous and oral administration to healthy volunteers: relationship to nonanalgesic actions.
    Westerling D; Persson C; Höglund P
    Ther Drug Monit; 1995 Jun; 17(3):287-301. PubMed ID: 7624926
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Population pharmacokinetics of oral morphine and its glucuronides in children receiving morphine as immediate-release liquid or sustained-release tablets for cancer pain.
    Hunt A; Joel S; Dick G; Goldman A
    J Pediatr; 1999 Jul; 135(1):47-55. PubMed ID: 10393603
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacokinetic modelling of morphine, morphine-3-glucuronide and morphine-6-glucuronide in plasma and cerebrospinal fluid of neurosurgical patients after short-term infusion of morphine.
    Meineke I; Freudenthaler S; Hofmann U; Schaeffeler E; Mikus G; Schwab M; Prange HW; Gleiter CH; Brockmöller J
    Br J Clin Pharmacol; 2002 Dec; 54(6):592-603. PubMed ID: 12492606
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The influence of renal function on the renal clearance of morphine and its glucuronide metabolites in intensive-care patients.
    Milne RW; Nation RL; Somogyi AA; Bochner F; Griggs WM
    Br J Clin Pharmacol; 1992 Jul; 34(1):53-9. PubMed ID: 1633068
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Disposition of morphine and its 3- and 6-glucuronide metabolites during morphine infusion in the sheep.
    Milne RW; Sloan PA; McLean CF; Mather LE; Nation RL; Runciman WB; Rutten AJ; Somogyi AA
    Drug Metab Dispos; 1993; 21(6):1151-6. PubMed ID: 7905398
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Morphine and morphine-6-glucuronide plasma concentrations and effect in cancer pain.
    Faura CC; Moore RA; Horga JF; Hand CW; McQuay HJ
    J Pain Symptom Manage; 1996 Feb; 11(2):95-102. PubMed ID: 8907140
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Morphine-3-glucuronide inhibits morphine induced, but enhances morphine-6-glucuronide induced locomotor activity in mice.
    Handal M; Ripel A; Aasmundstad T; Skurtveit S; Mørland J
    Pharmacol Biochem Behav; 2007 Mar; 86(3):576-86. PubMed ID: 17343905
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Morphine, morphine-6-glucuronide and morphine-3-glucuronide pharmacokinetics in newborn infants receiving diamorphine infusions.
    Barrett DA; Barker DP; Rutter N; Pawula M; Shaw PN
    Br J Clin Pharmacol; 1996 Jun; 41(6):531-7. PubMed ID: 8799518
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Start of oral morphine to cancer patients: effective serum morphine concentrations and contribution from morphine-6-glucuronide to the analgesia produced by morphine.
    Klepstad P; Kaasa S; Borchgrevink PC
    Eur J Clin Pharmacol; 2000 Jan; 55(10):713-9. PubMed ID: 10663448
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.